Top Markets
Coin of the day
Jeisys Medical Inc. Jeisys Medical Inc.

Jeisys Medical Inc.

287410
Rangering i aksjer #11660
Jeisys Medical Inc. is a company dedicated to the innovation and production of... Jeisys Medical Inc. is a company dedicated to the innovation and production of medical equipment, catering to a range of healthcare professionals including plastic surgeons, dermatologists, and other clinicians. Operating from its headquarters in Seoul, South Korea, the firm serves both its domestic market and international clients. Its comprehensive product line addresses various aesthetic and dermatological concerns, offering solutions for skin revitalization, firming, pigment correction, fat reduction, acne treatment, tattoo removal, and the management of scars and stretch marks. These advanced systems are branded under names such as ULTRAcel Q+, Cellec V, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, SmoothCool, and ULTRAcel. The company distributes its offerings through an extensive network of partners. Jeisys Medical Inc. was established in 2001.
Aksjekurs
$8.92
Sist synkronisert: 2024-10-18
Markedsverdi
$674.03M
Endring (1 dag)
-5.14%
Endring (1 år)
0.00%
Land
KR
Handel Jeisys Medical Inc. (287410)

Kategori

Inntekter for Jeisys Medical Inc. (287410)
Inntekter i Jun 2024 TTM: $121.50M
Ifølge de nyeste økonomiske rapportene til Jeisys Medical Inc. er selskapets nåværende inntekter (TTM) $121.50M. I 2022 hadde selskapet inntekter på $92.36M en økning sammenlignet med inntektene i 2021, som var $68.38M. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Jeisys Medical Inc. fra 2020 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $121.50M 9.97%
2023 $110.49M 19.63%
2022 $92.36M 35.07%
2021 $68.38M 55.21%
2020 $44.06M 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$46.59B 38,242.06%
US
$25.84B 21,165.30%
US
$35.48B 29,105.32%
IE
$21.00B 17,180.88%
US
- -
DE